Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Signet Therapeutics

Clinical trials sponsored by Signet Therapeutics, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New hope for advanced cancer: first human trial of SIGX1094R begins Results expected Oct 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New hope for advanced cancer: first human trial of SIGX1094R begins

Disease control Recruiting now

This early-stage study tests a new drug called SIGX1094R in about 102 adults with advanced solid tumors who have no standard treatment left. The main goals are to check the drug's safety, find the right dose, and see how it affects tumors. Researchers will also look at how food c…

Phase 1 • Sponsor: Signet Therapeutics • Aim: Disease control

Last updated Jun 27, 2026 12:33 UTC